TAMOXIFEN MARKET ANALYSIS

Regional Analysis

Tamoxifen Market – Regional Insights

On the basis of region, the global tamoxifen market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America tamoxifen market holds the dominant position, owing to high acceptance and high price of the drug in treating breast cancer. For instance, according to GoodRx Inc. 2018 pricing detail, 30 tablets of tamoxifen 20mg cost around US$ 65.71 on an average. Moreover, increasing prevalence of breast cancer has propelled the tamoxifen market growth in the North America region. According to 2018, U.S. Breast Cancer Organization statistics, around 1 in 8 U.S. women are estimated to develop invasive breast cancer during the course of her life. Moreover, around 266,120 women are expected to be diagnosed with invasive breast cancer in the U.S. in 2018.

Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to its increasing number of people vulnerable to various chronic diseases and increasing healthcare initiatives. For instance, according to published article in the Lancet Oncology 2014, breast cancer is expected to rise from less than 60 cases per 100,000 woman aged 55-69 years to over 100 cases per 100,000 woman by 2021, reaching 2.5 million cases overall by 2021.